XBI Holdings — SPDR® S&P® Biotech ETF
All 159 reported holdings of SPDR® S&P® Biotech ETF (XBI) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| State Street Global Advisors | 5.91% | $634.94M |
| Apogee Therapeutics Inc | 1.49% | $159.76M |
| Moderna Inc | 1.41% | $151.61M |
| Twist Bioscience Corp | 1.41% | $151.14M |
| Oruka Therapeutics Inc | 1.38% | $147.99M |
| Kymera Therapeutics Inc | 1.36% | $145.95M |
| Viking Therapeutics Inc | 1.30% | $139.97M |
| Praxis Precision Medicines Inc | 1.29% | $138.52M |
| Erasca Inc | 1.27% | $136.43M |
| Revolution Medicines Inc | 1.20% | $129.32M |
| Rhythm Pharmaceuticals Inc | 1.20% | $128.98M |
| CG oncology Inc | 1.20% | $128.81M |
| SELLAS Life Sciences Group Inc | 1.19% | $127.74M |
| Vaxcyte Inc | 1.19% | $127.43M |
| Dianthus Therapeutics Inc | 1.18% | $127.01M |
| Cytokinetics Inc | 1.18% | $126.46M |
| Natera Inc | 1.16% | $124.85M |
| Scholar Rock Holding Corp | 1.16% | $124.20M |
| Roivant Sciences Ltd | 1.16% | $124.03M |
| Mirum Pharmaceuticals Inc | 1.16% | $124.00M |
| Cogent Biosciences Inc | 1.14% | $122.79M |
| Ultragenyx Pharmaceutical Inc | 1.14% | $122.44M |
| Travere Therapeutics Inc | 1.13% | $121.01M |
| Alkermes PLC | 1.11% | $119.00M |
| Krystal Biotech Inc | 1.10% | $118.47M |
| Celcuity Inc | 1.10% | $118.05M |
| Relay Therapeutics Inc | 1.10% | $117.96M |
| Spyre Therapeutics Inc | 1.10% | $117.73M |
| TG Therapeutics Inc | 1.09% | $117.34M |
| Beam Therapeutics Inc | 1.08% | $115.87M |
| Insmed Inc | 1.08% | $115.55M |
| Protagonist Therapeutics Inc | 1.07% | $115.39M |
| Arrowhead Pharmaceuticals Inc | 1.07% | $114.73M |
| Vera Therapeutics Inc | 1.06% | $113.72M |
| Vertex Pharmaceuticals Inc | 1.06% | $113.49M |
| Madrigal Pharmaceuticals Inc | 1.06% | $113.43M |
| AbbVie Inc | 1.04% | $111.38M |
| Biogen Inc | 1.03% | $110.74M |
| PTC Therapeutics Inc | 1.03% | $110.73M |
| Halozyme Therapeutics Inc | 1.03% | $110.55M |
| uniQure NV | 1.03% | $110.38M |
| Bridgebio Pharma Inc | 1.02% | $110.02M |
| CRISPR Therapeutics AG | 1.02% | $109.84M |
| ImmunityBio Inc | 1.02% | $109.40M |
| Summit Therapeutics Inc | 1.01% | $108.59M |
| Ionis Pharmaceuticals Inc | 1.00% | $107.68M |
| Incyte Corp | 1.00% | $107.12M |
| Amgen Inc | 0.99% | $106.78M |
| Neurocrine Biosciences Inc | 0.97% | $104.32M |
| Gilead Sciences Inc | 0.96% | $103.54M |
| Regeneron Pharmaceuticals Inc | 0.96% | $103.18M |
| Exelixis Inc | 0.96% | $103.04M |
| Alnylam Pharmaceuticals Inc | 0.96% | $102.92M |
| BioMarin Pharmaceutical Inc | 0.94% | $101.43M |
| ACADIA Pharmaceuticals Inc | 0.94% | $100.62M |
| Nuvalent Inc | 0.93% | $99.69M |
| Immunovant Inc | 0.92% | $99.27M |
| United Therapeutics Corp | 0.92% | $99.18M |
| Intellia Therapeutics Inc | 0.91% | $97.40M |
| GRAIL Inc | 0.91% | $97.32M |
| BioCryst Pharmaceuticals Inc | 0.89% | $95.82M |
| Catalyst Pharmaceuticals Inc | 0.87% | $93.83M |
| Dyne Therapeutics Inc | 0.86% | $92.22M |
| Tango Therapeutics Inc | 0.84% | $90.37M |
| Denali Therapeutics Inc | 0.83% | $89.39M |
| Veracyte Inc | 0.82% | $87.89M |
| Ideaya Biosciences Inc | 0.80% | $86.26M |
| Recursion Pharmaceuticals Inc | 0.76% | $81.24M |
| Sarepta Therapeutics Inc | 0.75% | $80.16M |
| Arcus Biosciences Inc | 0.74% | $79.78M |
| Syndax Pharmaceuticals Inc | 0.72% | $77.12M |
| Arcutis Biotherapeutics Inc | 0.71% | $76.41M |
| Mineralys Therapeutics Inc | 0.71% | $76.10M |
| Celldex Therapeutics Inc | 0.70% | $75.39M |
| Agios Pharmaceuticals Inc | 0.69% | $74.42M |
| Viridian Therapeutics Inc | 0.67% | $72.08M |
| Novavax Inc | 0.66% | $70.93M |
| Disc Medicine Inc | 0.65% | $70.11M |
| ADMA Biologics Inc | 0.61% | $65.23M |
| Immunome Inc | 0.59% | $63.40M |
| Palvella Therapeutics Inc | 0.58% | $62.45M |
| Iovance Biotherapeutics Inc | 0.56% | $60.29M |
| Absci Corp | 0.56% | $59.94M |
| Nurix Therapeutics Inc | 0.56% | $59.66M |
| Kodiak Sciences Inc | 0.54% | $58.25M |
| Biohaven Ltd | 0.53% | $56.41M |
| Vericel Corp | 0.49% | $53.13M |
| AnaptysBio Inc | 0.49% | $53.10M |
| Capricor Therapeutics Inc | 0.49% | $52.45M |
| Stoke Therapeutics Inc | 0.48% | $51.49M |
| Monte Rosa Therapeutics Inc | 0.48% | $51.15M |
| Vir Biotechnology Inc | 0.47% | $50.39M |
| Hyperliquid Strategies Inc | 0.46% | $49.81M |
| Tyra Biosciences Inc | 0.41% | $44.47M |
| Corvus Pharmaceuticals Inc | 0.41% | $43.80M |
| Cullinan Therapeutics Inc | 0.40% | $43.30M |
| Precigen Inc | 0.38% | $40.39M |
| Inhibrx Biosciences Inc | 0.35% | $38.00M |
| Taysha Gene Therapies Inc | 0.35% | $37.90M |
| Ardelyx Inc | 0.35% | $37.83M |
| Avalo Therapeutics Inc | 0.35% | $37.51M |
| MannKind Corp | 0.34% | $36.29M |
| Annexon Inc | 0.33% | $35.60M |
| ORIC Pharmaceuticals Inc | 0.33% | $35.36M |
| Zenas Biopharma Inc | 0.32% | $34.25M |
| Jade Biosciences Inc | 0.32% | $34.08M |
| Kura Oncology Inc | 0.32% | $34.07M |
| Olema Pharmaceuticals Inc | 0.32% | $33.99M |
| CareDx Inc | 0.30% | $32.59M |
| Bicara Therapeutics Inc | 0.30% | $32.56M |
| Vor BioPharma Inc | 0.30% | $32.33M |
| Xencor Inc | 0.29% | $31.23M |
| ArriVent Biopharma Inc | 0.28% | $30.59M |
| Replimune Group Inc | 0.28% | $30.49M |
| CytomX Therapeutics Inc | 0.28% | $29.87M |
| Janux Therapeutics Inc | 0.28% | $29.62M |
| Sionna Therapeutics Inc | 0.27% | $28.49M |
| Geron Corp | 0.26% | $27.93M |
| Solid Biosciences Inc | 0.24% | $25.80M |
| Rigel Pharmaceuticals Inc | 0.24% | $25.44M |
| Allogene Therapeutics Inc | 0.24% | $25.26M |
| Sana Biotechnology Inc | 0.23% | $24.70M |
| Altimmune Inc | 0.23% | $24.61M |
| REGENXBIO Inc | 0.22% | $23.47M |
| Ironwood Pharmaceuticals Inc | 0.22% | $23.15M |
| Immix Biopharma Inc | 0.20% | $21.69M |
| Ocugen Inc | 0.20% | $21.40M |
| 4D Molecular Therapeutics Inc | 0.20% | $21.39M |
| Candel Therapeutics Inc | 0.19% | $20.85M |
| Savara Inc | 0.18% | $19.69M |
| Prime Medicine Inc | 0.18% | $19.29M |
| First Tracks Biotherapeutics Inc | 0.17% | $18.72M |
| Damora Therapeutics Inc | 0.17% | $18.60M |
| ARS Pharmaceuticals Inc | 0.17% | $18.32M |
| MapLight Therapeutics Inc | 0.17% | $17.86M |
| Arbutus Biopharma Corp | 0.16% | $17.64M |
| Myriad Genetics Inc | 0.16% | $17.22M |
| Cabaletta Bio Inc | 0.15% | $16.35M |
| Compass Therapeutics Inc | 0.14% | $14.98M |
| Emergent BioSolutions Inc | 0.13% | $14.30M |
| Prothena Corp PLC | 0.13% | $14.23M |
| Vanda Pharmaceuticals Inc | 0.13% | $14.03M |
| Perspective Therapeutics Inc | 0.13% | $13.76M |
| Ovid therapeutics Inc | 0.12% | $13.24M |
| Verastem Inc | 0.12% | $12.95M |
| MiMedx Group Inc | 0.11% | $11.38M |
| Lexeo Therapeutics Inc | 0.11% | $11.31M |
| Achieve Life Sciences Inc | 0.08% | $8.81M |
| Sagimet Biosciences Inc | 0.07% | $7.60M |
| Contra Metsera, Inc. | 0.07% | $7.50M |
| BridgeBio Oncology Therapeutics Inc | 0.06% | $6.20M |
| Contra Akero Therapeut | 0.01% | $1.32M |
| Contra Inhibrx, Inc. | 0.01% | $1.07M |
| Contra Mirati Therapeu | 0.01% | $958.69K |
| Contra Verve Therapeut | 0.01% | $567.17K |
| Contra Blueprint Medic | 0.00% | $347.98K |
| Omniab, Inc. | 0.00% | $0 |
| Atrium Therapeutics Inc | 0.00% | $7 |
| Omniab, Inc. | 0.00% | $0 |